Search

Displaying results 9021 - 9030 of 9220 in total
  1. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  2. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  3. Drug

    MVA-BN-HER-2

    go.drugbank.com/drugs/DB05733
    Experimental

  4. Drug

    Tasquinimod

    go.drugbank.com/drugs/DB05861
    Investigational

    The quinoline-3-carboxamide anti-angiogenic agent, tasquinimod, enhances the anti-prostate cancer efficacy of androgen ablation and taxotere without effecting serum PSA directly in human xenografts

  5. Drug

    Istaroxime

    go.drugbank.com/drugs/DB06157
    Investigational

  6. Drug

    Indibulin

    go.drugbank.com/drugs/DB06169
    Investigational

  7. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.

  8. Drug

    Cantuzumab ravtansine

    go.drugbank.com/drugs/DB05594
    Investigational

  9. Drug

    OTI-030

    go.drugbank.com/drugs/DB05648
    Investigational

  10. Drug

    Iodofiltic acid I-123

    go.drugbank.com/drugs/DB05683
    Investigational